Brief: Eton Pharmaceuticals Q1 Net Income USD -1.572 Million
13/05/2025 21:01
May 13 (Reuters) - Eton Pharmaceuticals Q1 gross profit USD 9.861 million. Q1 pretax profit USD -1.498 million Q1 income from operations USD -470 thousand Q1 operating expenses USD 10.331 million Q1 basic EPS USD -0.06
Recent news on Eton Pharmaceuticals
See all newsBrief: Eton Pharmaceuticals Under Agreement, Co Pays Aquestive Upfront License Fee Of $10 Million - SEC Filing
Aquestive rises on US licensing deal for seizure drug with Eton Pharma
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer